Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $114.7000 (-0.03%) ($113.8800 - $115.2840) on Tue. Jun. 22, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.04% (three month average) | RSI | 66 | Latest Price | $114.7000(-0.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.2% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.9% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(44%) SPLV(35%) VYM(32%) XLP(32%) DIA(31%) | Factors Impacting ABBV price | ABBV will decline at least -0.52% in a week (0% probabilities). VIXM(-21%) UUP(-10%) VXX(-2%) TLT(-2%) KWEB(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.52% (StdDev 1.04%) | Hourly BBV | 0.6 () | Intraday Trend | 0.2% | | | |
|
5 Day Moving Average | $114.6(0.09%) | 10 Day Moving Average | $114.97(-0.23%) | 20 Day Moving Average | $113.95(0.66%) | To recent high | -2.1% | To recent low | 11.3% | Market Cap | $202.363b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |